CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in ac...
CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia
About this item
Full title
Author / Creator
Liu, Yongliang , Wang, Guiqin , Zhang, Jiasi , Chen, Xue , Xu, Huailong , Heng, Gang , Chen, Jun , Zhao, Yongchun , Li, Jiatao , Ni, Yuanli , Zhang, Yingzi , Shan, Juanjuan and Cheng, Qian
Publisher
Durham: Research Square
Journal title
Language
English
Formats
Publication information
Publisher
Durham: Research Square
Subjects
More information
Scope and Contents
Contents
Background: Leukemia stem cells (LSCs) are responsible for the initiation, progression and relapse of acute myeloid leukemia (AML). Therefore, a therapeutic strategy targeting LSCs is a potential approach to eradicate AML. In this study, we aimed to identify LSC-specific surface markers and uncover the underlying mechanism of AML LSCs. Methods: Mic...
Alternative Titles
Full title
CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2532769544
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2532769544
Other Identifiers
DOI
10.21203/rs.3.rs-55355/v3
How to access this item
https://www.proquest.com/docview/2532769544?pq-origsite=primo&accountid=13902
